Ecolab Stock (NYSE:ECL)
Previous Close
$272.21
52W Range
$243.15 - $309.27
50D Avg
$278.57
200D Avg
$273.03
Market Cap
$76.44B
Avg Vol (3M)
$1.44M
Beta
0.89
Div Yield
$2.84 (1.05%)
ECL Company Profile
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
ECL Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Global Life Sciences | $747.90M | - | - |
| Global Water | $7.98B | - | - |
| Global Pest Elimination | $1.25B | $1.17B | - |
| Global Institutional and Specialty | $6.10B | $5.41B | $5.00B |
| Global Industrial | - | $7.86B | $7.22B |
| Global Healthcare and Life Sciences | - | $1.43B | $1.59B |
| Corporate Segment | - | - | $69.00M |
| Other | - | - | $1.44B |
Fiscal year ends in Dec 25 | Currency in USD